‘Gene repair’ could be tested on people in 2017: Start-up wants to use controversial technique to treat hereditary blindness

Human trials of Crispr editing are being proposed by Massachusetts-based start-up Editas Medicine to treat a rare form of blindness knwon as Leber congenital amaurosis. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail